TickerFacts.

A business in context

RMD research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-02 · 0000943819-26-000050

  2. 8-K · Current report

    Report date 2026-08-31 · 0001193125-26-378487 · Items 8.01

  3. 8-K · Current report

    Report date 2026-08-13 · 0001193125-26-354154 · Items 4.01,5.02,7.01,9.01

  4. 10-K · Annual report

    Report date 2026-06-30 · 0000943819-26-000047

  5. 4 · Ownership change

    Report date 2026-08-07 · 0000943819-26-000043

  6. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-337962 · Items 2.02,8.01,9.01

  7. 4 · Ownership change

    Report date 2026-08-05 · 0000943819-26-000040

  8. 4 · Ownership change

    Report date 2026-07-07 · 0000943819-26-000038

  9. 8-K · Current report

    Report date 2026-06-30 · 0001193125-26-297658 · Items 2.02,7.01,9.01

  10. 4 · Ownership change

    Report date 2026-06-08 · 0000943819-26-000035

  11. 4 · Ownership change

    Report date 2026-06-01 · 0000943819-26-000033

  12. 4 · Ownership change

    Report date 2026-05-07 · 0000943819-26-000030

  13. 4 · Ownership change

    Report date 2026-05-04 · 0000943819-26-000027

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000943819-26-000025

  15. 8-K · Current report

    Report date 2026-04-24 · 0001193125-26-197282 · Items 5.02,9.01

  16. 8-K · Current report

    Report date 2026-04-30 · 0001193125-26-197192 · Items 2.02,8.01,9.01

  17. 10-Q · Quarterly report

    Report date 2025-12-31 · 0000943819-26-000007

  18. 8-K · Current report

    Report date 2026-01-29 · 0001193125-26-029326 · Items 2.02,8.01,9.01

  19. 8-K · Current report

    Report date 2025-11-19 · 0001193125-25-289878 · Items 5.02,5.07,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000943819-25-000090

  21. 8-K · Current report

    Report date 2025-10-30 · 0001193125-25-258519 · Items 2.02,8.01,9.01

  22. DEF 14A · Proxy statement

    Report date 2025-06-30 · 0000943819-25-000079

  23. 8-K · Current report

    Report date 2025-08-15 · 0001193125-25-182695 · Items 5.02,9.01

  24. 10-K · Annual report

    Report date 2025-06-30 · 0000943819-25-000035

  25. 8-K · Current report

    Report date 2025-07-28 · 0001193125-25-170718 · Items 5.02

  26. 8-K · Current report

    Report date 2025-07-31 · 0001193125-25-170512 · Items 2.02,8.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000943819-25-000008

  28. 8-K · Current report

    Report date 2025-04-23 · 0001193125-25-091357 · Items 2.02,8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2024-12-31 · 0000943819-25-000004

  30. 8-K · Current report

    Report date 2025-01-30 · 0001193125-25-017218 · Items 2.02,8.01,9.01

  31. 8-K · Current report

    Report date 2024-11-20 · 0001193125-24-263501 · Items 5.07

  32. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000943819-24-000027

  33. 8-K · Current report

    Report date 2024-10-24 · 0001193125-24-242806 · Items 2.02,8.01,9.01

  34. DEF 14A · Proxy statement

    Report date 2024-06-30 · 0000943819-24-000019

  35. 8-K · Current report

    Report date 2024-08-15 · 0001193125-24-202204 · Items 5.02,9.01

  36. 10-K · Annual report

    Report date 2024-06-30 · 0000943819-24-000013

  37. 8-K · Current report

    Report date 2024-08-01 · 0001193125-24-191487 · Items 2.02,8.01,9.01

  38. 10-Q · Quarterly report

    Report date 2024-03-31 · 0000943819-24-000008

  39. 8-K · Current report

    Report date 2024-04-25 · 0001193125-24-113883 · Items 2.02,8.01,9.01

  40. SC 13G/A · Ownership disclosure

    0001104659-24-021831

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 5 transaction rows5SGrant / award: 0 transaction rows0AExercise / conversion: 6 transaction rows6MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

12 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-08
2026-06-09
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
ResMed Common Stock4991.0146.34
2026-06-08
2026-06-09
Farrell Michael J.
10b5-1 checkbox reported
S · Sale
Disposed
ResMed Common Stock4991.0193.96
2026-06-08
2026-06-09
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
ResMed Common Stock Options
Derivative security
4991.00.0
2026-06-01
2026-06-03
Rider Michael JF · Tax / exercise payment
Disposed
ResMed Common Stock268.74190.57
2026-05-07
2026-05-11
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
ResMed Common Stock4991.0146.34
2026-05-07
2026-05-11
Farrell Michael J.
10b5-1 checkbox reported
S · Sale
Disposed
ResMed Common Stock4991.0207.82
2026-05-07
2026-05-11
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
ResMed Common Stock Options
Derivative security
4991.00.0
2026-04-07
2026-04-09
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
ResMed Common Stock4991.0146.34
2026-04-07
2026-04-09
Farrell Michael J.
10b5-1 checkbox reported
S · Sale
Disposed
ResMed Common Stock4991.0225.5
2026-04-07
2026-04-09
Farrell Michael J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
ResMed Common Stock Options
Derivative security
4991.00.0
2026-04-01
2026-04-03
Sandercock Brett
10b5-1 checkbox reported
S · Sale
Disposed
ResMed Common Stock1000.0224.31
2026-04-01
2026-04-02
FARRELL PETER C
10b5-1 checkbox reported
S · Sale
Disposed
ResMed Common Stock2000.0225.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000943819RESMED INC
ResMed (Germany)ResMed (Australia)

Showing 2 of 2 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • ResMed · alias · wikidata
  • RMD · alias · wikidata
  • ResMed (Germany) · subsidiary · wikidata
  • ResMed (Australia) · subsidiary · wikidata
  • RESMED INC · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2025-06-30$5.15B$5.41B
2024-06-30$4.69B$5.05B
2023-06-30$4.22B$4.71B
2022-06-30$3.58B$4.24B
2021-06-30$3.20B$4.06B
2020-06-30$2.96B$3.84B
2019-06-30$2.61B$3.44B
2018-06-30$2.34B$3.15B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗